Bright Minds Biosciences Inc. Company Profile
NASDAQ: DRUGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bright Minds Biosciences at a glance
Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY, Canada. Bright Minds Biosciences is led by Mr. Ian McDonald and employs about 26 people. At a market capitalization of $533.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001827401, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Bright Minds Biosciences do?
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Bright Minds Biosciences Inc.
- Ticker
- NASDAQ: DRUG
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Ian McDonald
- Employees
- 26
- Headquarters
- 19 Vestry Street, New York, NY, Canada
- Phone
- 647 865 8622
- Website
- brightmindsbio.com
- Market cap
- $533.15M
- SEC CIK
- 0001827401
Companies similar to Bright Minds Biosciences
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PBYIPuma Biotechnology Inc | 10.29 | +3.21% | $531.17M | vs DRUG |
| MNPRMonopar Therapeutics Inc. | 78.96 | -5.98% | $529.99M | vs DRUG |
| NGNENeurogene Inc. | 26.40 | -0.38% | $528.30M | vs DRUG |
| EVOEvotec SE ADR | 1.53 | -2.55% | $543.75M | vs DRUG |
| OCSOculis Holding AG | 8.34 | -3.70% | $513.64M | vs DRUG |
| CBIOCrescent Biopharma Inc. | 14.91 | +5.59% | $553.86M | vs DRUG |
| BLSMBlossomHill Therapeutics Inc. | 17.48 | +3.55% | $555.60M | vs DRUG |
| EOLSEvolus Inc. | 7.73 | -0.90% | $510.57M | vs DRUG |